Clinical study of endoscopic surgery for recurrent nasopharyngeal carcinoma.
10.13201/j.issn.2096-7993.2023.10.002
- Author:
Yin HE
1
;
Hai YIN
1
;
Jiasen WU
1
;
Wen ZHENG
1
Author Information
1. Department of Otorhinolaryngology Head and Neck Surgery，Guigang People's Hospital，Guigang，537100，China.
- Publication Type:Journal Article
- Keywords:
nasal septal mucosal flap;
nasopharyngeal tumors;
recurrence;
surgical treatment;
temporal muscle flap
- MeSH:
Humans;
Plastic Surgery Procedures;
Nasopharyngeal Carcinoma/surgery*;
Retrospective Studies;
Quality of Life;
Skull Base/surgery*;
Nose Diseases/pathology*;
Nasopharyngeal Neoplasms/pathology*
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2023;37(10):771-777
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To compare the clinical effects and complications of surgery + chemotherapy and radiotherapy + chemotherapy in patients with nasopharyngeal carcinoma recurrence, so as to compare the safety and efficacy of two different therapeutic methods. Methods:A retrospective analysis was performed on 40 patients with recurrent nasopharyngeal carcinoma after radiotherapy and chemotherapy admitted to our hospital from January 2016 to June 2020. Among them, 26 patients were treated with surgery. The recurrent tumor was removed under nasal endoscope, and the frozen resection margin was negative during the operation. Chemotherapy was continued for stage Ⅲ and Ⅳ patients from 3 to 5 weeks after surgery. Fourteen patients received secondary radiotherapy and chemotherapy. Postoperative complications and survival rate were observed. Results:There were 14 patients in the secondary chemoradiotherapy group（control group） and 26 patients in the nasal endoscopic surgery group（observation group）. Among the 26 patients, 19 patients underwent nasal septal mucosal repair, 5 patients underwent temporal muscle flap repair, 2 patients underwent submental flap repair, 2 patients had nasal septal mucosal flap necrosis and cerebrospinal fluid leakage, and the temporal muscle flap was used for secondary repair in the second stage operation, and 8 patients needed cervical lymph node dissection. The patients recovered well after surgery, and the patients in stage Ⅲ and Ⅳ were treated with chemotherapy after 3 weeks to 5 weeks according to the patient's wound condition. There were significant differences in the incidence of complications and 1-, 2-, and 3-year survival rates between the two groups（P<0.05）. Conclusion:Patients with recurrent nasopharyngeal carcinoma can be treated by nasal endoscopic surgery to remove the tumor, and the use of pedicled nasal septal mucosal flap or temporal muscle flap for skull base reconstruction, The operation can effectively prevent major complications such as internal carotid artery rupture and hemorrhage, and improve the survival rate and quality of life of patients. It provides a safe and effective treatment for patients with recurrent nasopharyngeal carcinoma.
